Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the same
US12325698B2 · kind B2 · utility
0Cited by
7References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 25, 2022 |
| Grant date | Jun 10, 2025 |
| Priority date | — |
| Expiry date | Dec 13, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/506
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are a pyrimidine compound represented by Formula 1, a method of preparing the compound, and a pharmaceutical use of the compound for the prevention or treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.